The yeast Sup35NM domain propagates as a prion in mammalian cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 2, 2009, Pages 462-467

  Krammer, Carmen ^a   Kryndushkin, Dmitry ^b   Suhre, Michael H ^c   Kremmer, Elisabeth ^d   Hofmann, Andreas ^e   Pfeifer, Alexander ^e   Scheibel, Thomas ^c   Wickner, Reed B ^b   Schätzl, Hermann M ^a   Vorberg, Ina ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF BAYREUTH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

PrP; Sup35

Indexed keywords

EPITOPE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; DAUGHTER CELL; FIBER; INHERITANCE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PHENOTYPE; PHYLOGENY; PRION; PRIORITY JOURNAL; PROTEIN DOMAIN; YEAST;

ANIMALS; MICE; MOLECULAR PROBE TECHNIQUES; NEUROBLASTOMA; PRION DISEASES; PRIONS; SACCHAROMYCES CEREVISIAE PROTEINS; TUMOR CELLS, CULTURED;

FUNGI; MAMMALIA; MURINAE;

EID: 58849091748     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0811571106     Document Type: Article

References (42)

1. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383.
2. Telling GC, et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082.
3. Cox BS (1965) [PSI], a cytoplasmic suppressor of super-suppressors in yeast. Heredity 20:505-521.
4. Wickner RB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264:566-569.
5. Paushkin SV, Kushnirov VV, Smirnov VN, Ter Avanesyan MD (1996) Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15:3127-3134.
6. King CY, et al. (1997) Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 94:6618-6622.
7. Lindquist S (1997) Mad cows meet psi-chotic yeast: The expansion of the prion hypothesis. Cell 89:495-498.
8. Glover JR, et al. (1997) Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 89:811-819.
9. Scheibel T (2004) Amyloid formation of a yeast prion determinant. J Mol Neurosci 23:13-22.
10. Ter Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN (1994) The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137:671-676.
11. Liu JJ, Sondheimer N, Lindquist SL (2002) Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci USA 99(Suppl 4):16446-16453.
12. Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001) Prions affect the appearance of other prions: The story of [PIN(+)]. Cell 106:171-182.
13. Chernoff YO (2004) Amyloidogenic domains, prionsandstructural inheritance: Rudiments of early life or recent acquisition? Curr Opin Chem Biol 8:665-671.
14. Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268:880-884.
15. Kryndushkin DS, Alexandrov IM, Ter Avanesyan MD, Kushnirov VV (2003) Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 278:49636-49643.
16. Krammer C, et al. (2008) Prion protein/protein interactions: Fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells. FASEB J 22:762-773.
17. Maddelein ML, Dos RS, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ (2002) Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci USA 99:7402-7407.
18. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428:323-328.
19. King CY, Diaz-Avalos R (2004) Protein-only transmission of three yeast prion strains. Nature 428:319-323.
20. Brachmann A, Baxa U, Wickner RB (2005) Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 24:3082-3092.
21. Patel BK, Liebman SW (2007) "Prion-proof" for [PIN(+)]: Infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN(+)]. J Mol Biol 365:773-782.
22. DePace AH, Weissman JS (2002) Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nat Struct Biol 9:389-396.
23. Hess S, Lindquist SL, Scheibel T (2007) Alternative assembly pathways of the amyloidogenic yeast prion determinant Sup35-NM. EMBO Rep 8:1196-1201.
24. Serio TR, et al. (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289:1317-1321.
25. Taneja V, Maddelein ML, Talarek N, Saupe SJ, Liebman SW (2007) A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. Mol Cell 27:67-77.
26. Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW (1996) Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144:1375-1386.
27. Tanaka M, Chien P, Yonekura K, Weissman JS (2005) Mechanism of cross-species prion transmission: An infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121:49-62.
28. Tessier PM, Lindquist S (2007) Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 447:556-561.
29. Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930-936.
30. Newnam GP, Wegrzyn RD, Lindquist SL, Chernoff YO (1999) Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing. Mol Cell Biol 19:1325-1333.
31. Chernoff YO, Newnam GP, Kumar J, Allen K, Zink AD (1999) Evidence for a protein mutator in yeast: Role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion. Mol Cell Biol 19:8103-8112.
32. Kushnirov VV, Kryndushkin DS, Boguta M, Smirnov VN, Ter Avanesyan MD (2000) Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr Biol 10:1443-1446.
33. Kryndushkin DS, Smirnov VN, Ter Avanesyan MD, Kushnirov VV (2002) Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions. J Biol Chem 277:23702-23708.
34. Asante EA, et al. (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21:6358-6366.
35. Lloyd SE, et al. (2004) Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol 85:2471-2478.
36. Kryndushkin D, Wickner RB (2007) Nucleotide exchange factors for Hsp70s are required for [URE3] prion propagation in Saccharomyces cerevisiae. Mol Biol Cell 18:2149-2154.
37. Fan Q, Park KW, Du Z, Morano KA, Li L (2007) The role of Sse1 in the de novo formation and variant determination of the [PSI+] prion. Genetics 177:1583-1593.
38. Lawson VA, et al. (2008) Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. Int J Biochem Cell Biol 40:2793-2801.
39. Mahal SP, et al. (2007) Prion strain discrimination in cell culture: The cell panel assay. Proc Natl Acad Sci USA 104:20908-20913.
40. Fowler DM, Koulov AV, Balch WE, Kelly JW (2007) Functional amyloid-from bacteria to humans. Trends Biochem Sci 32:217-224.
41. Balguerie A, et al. (2003) Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J 22:2071-2081.
42. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25:217-222.